28 Days at 3,500 m: What Tibet Altitude Does Week by Week

The Tibet motorcycle tour is one of the few civilian travel experiences that puts a foreign rider above 3,500 metres for four consecutive weeks. The 20-day Tibet and Shangri-La tour, the longer Kailash extension, and the multi-week Lhasa-to-Everest itineraries all share this characteristic: your body never returns to sea-level oxygen across the entire trip. Most altitude advice for Tibet visitors stops at week one, the acute mountain sickness window when you need to be most careful. What happens in weeks two, three, and four is less discussed and arguably more interesting. Your body adapts. It also pays for the adaptation. And then, when you descend to Bangkok or Kathmandu at the end of the trip and breathe sea-level oxygen again for the first time in a month, your body has to undo the adaptation in a process that takes another ten days. This is the week-by-week physiological story.

Why this matters before you book

The Tibet plateau average elevation is around 4,500 metres. Lhasa sits at 3,650. The Friendship Highway between Lhasa and Kathmandu crosses passes at 5,200 metres and higher. The Kailash extension to Ngari adds further days at 4,500 to 5,100 metres. A foreign rider on the full Tibet expedition therefore spends 14 to 28 days at altitudes that produce measurable physiological changes within hours and progressive cumulative changes over weeks. The Sherpa and Tibetan populations who live at these altitudes year-round are genetically adapted through a different mechanism — the EPAS1 gene variants that confer high-altitude tolerance without the cardiovascular cost paid by visitors. Foreign rider adaptation is temporary, real, and the same biological response that produces it produces the trade-offs that ride alongside it.

The published physiological literature on altitude acclimatization is extensive. The AltitudeOmics study, published in PLOS One in 2014, tracked detailed haematological and physiological changes in healthy volunteers at 5,260 metres over an extended period. The Wilderness Medical Society consensus guidelines, updated 2024, summarise the practical clinical implications. The High Altitude Medicine and Biology journal publishes the ongoing research. For a motorcycle rider considering Tibet, the operational implication of the science is that the same trip behaves differently in week one than in week four, and pacing the trip around the body’s actual adaptation curve produces better outcomes than treating every day as identical.

Sigrid, a Stockholm-based emergency-medicine physician on a 2024 BBT Tibet and Shangri-La tour who tracked her own resting heart rate and oxygen saturation daily with a finger pulse oximeter, said afterward that the data fitted the published acclimatization curves almost exactly. Her SpO2 dropped from 98 percent at sea level to 84 percent on day one in Lhasa, climbed back to 92 percent by day ten, and was still at 94 percent on her last day in Tibet. Her resting heart rate rose from 58 bpm at sea level to 76 bpm in the first week and stabilised at 68 bpm by week three. The numbers tell the adaptation story in real time.

Week one: the AMS window

The first seven days at altitude are the AMS (acute mountain sickness) window. AMS is a clinical syndrome defined by headache plus at least one of nausea, fatigue, dizziness, or sleep disturbance, occurring within the first 24 to 48 hours of altitude exposure and resolving within three to five days for most affected individuals. The CDC’s altitude illness guidelines estimate that 25 percent of unacclimatized visitors to 3,500 metres develop AMS, rising to 50 percent at 4,500 metres. For Tibet motorcycle tours starting in Lhasa at 3,650 metres, the AMS rate in foreign riders typically runs 40 to 60 percent in the first week, with most cases mild and self-limiting.

The physiological process driving week-one symptoms is the body’s initial response to reduced oxygen partial pressure. Within hours of arrival, the kidneys begin excreting bicarbonate to compensate for the respiratory alkalosis caused by hyperventilation. Plasma volume contracts to concentrate red blood cells, raising hematocrit by mechanical concentration rather than new cell production. The carotid bodies detect the lower oxygen and increase respiratory drive. The cumulative effect is a body that’s working harder to deliver less oxygen, and the resulting fatigue, headache, and sleep disturbance are the symptoms.

Diamox (acetazolamide), the standard prophylactic, accelerates the kidney bicarbonate excretion and reduces AMS incidence by roughly 50 percent in randomised controlled trials reviewed in the Cochrane database. The standard preventive dose is 125 to 250 mg twice daily, started 24 hours before going above 3,500 metres, continued for the first two to four days at altitude. Side effects include increased urination, mild tingling in the fingers, and a flat taste to carbonated drinks. Riders with sulfa allergies cannot take it. Riders who can take it should — the data is solid.

Hydration math at altitude is brutal in the first week. Respiratory water loss at 4,000 metres is roughly two to three times sea-level baseline, and the dry plateau air compounds the effect. The standard prescription is four to five litres of water per day, more if the riding is physically demanding. Riders who ration water because they don’t want to stop end up with concentrated urine, kidney irritation, and worse AMS. Lucas, a Munich-based architect on a 2024 BBT Tibet tour, lost the first three days of his trip to AMS that resolved as soon as he doubled his water intake on day four. His self-assessment afterward: “I thought I was tough enough not to need the water. I was wrong.”

Week two: the adaptation kicks in

Around day eight to fourteen, the body’s adaptive response shifts from emergency compensation to sustained adaptation. Erythropoietin (EPO) levels, which spike within hours of altitude exposure, drive measurable new red blood cell production through the second week. Hematocrit, which initially rose by hemoconcentration in week one, now continues rising through actual erythropoiesis. The cardiovascular system adjusts to the higher viscosity blood and the increased oxygen-carrying capacity. Most riders report feeling substantially better in week two than week one. The AMS symptoms have resolved. The body is functioning at altitude rather than struggling at altitude.

The trade-off in week two is that the underlying cardiovascular load remains elevated even as the symptoms disappear. Resting heart rate stays 10 to 20 bpm above sea-level baseline. Blood pressure rises modestly. Sleep architecture is genuinely altered — REM sleep decreases by 20 to 30 percent, sleep efficiency drops, and the periodic-breathing pattern called Cheyne-Stokes respiration becomes common during sleep above 4,000 metres. Riders may feel rested in the morning but their actual restorative sleep is compromised. The cumulative effect is subtle fatigue that builds across the week.

Appetite changes are the third week-two phenomenon. Most riders experience decreased appetite at altitude, partly due to the metabolic effects of hypoxia and partly due to the slowed gastric emptying that accompanies altitude exposure. Food intake commonly drops by 10 to 20 percent in week two. Combined with the energy demands of long riding days, this creates a small caloric deficit that accumulates. Forcing higher food intake through deliberate snacking — energy bars, dried fruit, the Tibetan tsampa barley flour mix that locals eat — is the practical countermeasure.

Konstantin, a Vienna-based commercial pilot on a 2024 BBT Tibet tour who normally weighs himself daily as part of his health monitoring, lost 1.8 kilograms in his second week at altitude despite eating what he considered normal portions. The weight loss reflected both reduced appetite and the metabolic cost of acclimatization. He recovered the weight in week three when he forced himself to eat extra snacks between meals. The intervention worked but required conscious effort.

Week three: the plateau

By day fifteen to twenty-one, the body has reached most of the adaptation it will achieve. Hematocrit stabilises at a new elevated level, typically 4 to 7 percentage points above the sea-level baseline. Oxygen-carrying capacity is substantially restored relative to week one. Resting heart rate may drop slightly from the week-two peak. Sleep quality improves modestly as the body adjusts to the periodic-breathing pattern. Most riders report week three as the most comfortable phase of the trip, where the AMS is fully behind them, the cardiovascular adaptation is complete, and the body feels capable.

The hidden cost in week three is the beginning of the muscle catabolism that prolonged altitude exposure produces in non-adapted populations. The increased erythropoiesis demands amino acids that the body partially sources from muscle protein breakdown. Sustained moderate-to-high physical exertion at altitude over multiple weeks produces measurable muscle mass loss in studies tracking AltitudeOmics-style cohorts. For a motorcycle rider, this manifests as gradually decreasing physical capacity for off-bike activities — the pre-trip ability to carry a heavy pannier up three flights of stairs becomes harder by week three. The riding itself is fine. The non-riding fitness is degrading.

Chronic mountain sickness (CMS), also called Monge’s disease, is the syndrome that develops in a minority of individuals from prolonged altitude exposure. CMS involves excessive erythropoiesis (hematocrit over 60 percent), pulmonary hypertension, and the symptoms of fatigue, dyspnoea on exertion, cyanosis, and confusion. CMS is rare in healthy visitors during a four-week trip — the disease typically develops over months to years of altitude residence — but susceptible individuals can show early features by week three of a Tibet expedition. Riders with pre-existing pulmonary disease, smokers, and individuals over 55 with cardiovascular risk factors should specifically be screened by their physician before a long Tibet trip.

The week-three psychological feature that catches riders unprepared is the emotional flattening that prolonged mild hypoxia produces. The cognitive literature describes this as “altitude irritability” or “the high-altitude personality change” — a small but measurable shift toward emotional flatness, slowed verbal processing, and decreased patience for complex social interactions. The effect is mild in most riders and disappears within hours of descent, but it’s real enough that group dynamics on long Tibet trips often turn slightly strained around day eighteen. The fix is awareness rather than intervention.

Week four: the diminishing returns

By day twenty-two through twenty-eight, the body has been at altitude long enough that the adaptive benefits and the cumulative costs are roughly balanced for the average healthy rider. Some changes have stabilised: hematocrit is at peak elevated level, heart rate at the new resting baseline, sleep at the adapted (still compromised) pattern. Other changes are starting to compound: cumulative muscle catabolism, sustained sleep deprivation across multiple weeks, the energy debt from chronic appetite suppression. Riders who feel best in week three often feel slightly worse in week four, even though the underlying physiology has not changed dramatically.

The cardiovascular strain becomes measurable in week four for older riders or those with subclinical heart issues. Resting blood pressure may continue to creep upward. The right ventricle, which has been working against increased pulmonary vascular resistance for three weeks, shows mild enlargement on echocardiography in many study cohorts at this duration. Most of this is reversible on descent. Some of it, in susceptible individuals, can trigger more serious cardiac events. The CDC’s altitude guidelines specifically flag this risk for individuals with known coronary artery disease and recommend cardiology clearance before any Tibet trip exceeding two weeks.

The “Tibet stare” is the colloquial name for the chronic mild hypoxia symptom complex that some week-four riders develop: slight cognitive slowness, reduced verbal fluency, the feeling of being slightly “out of phase” with social interactions. The Sherpa and Tibetan populations don’t have this because their genetic adaptation prevents it. Foreign visitors do have it because their adaptation is partial. The condition resolves completely on descent, usually within 48 hours. While present, it can affect riding decisions, navigation, and the willingness to engage with complex group logistics.

Amélie, a Bordeaux-based oncologist on a 2024 BBT Tibet and Shangri-La tour with the Kailash extension, who completed the full 28-day itinerary, said afterward that the photographs from her last week showed her face looking visibly different — slightly puffier, slightly less alert — than the photographs from her first week. She attributed this to the cumulative altitude exposure rather than the riding fatigue alone. Three weeks after returning to sea level, she said, the puffiness was gone and the alertness was back. The change had been entirely altitude-driven.

The descent reverse: J+1 through J+10

The first 24 to 48 hours after descending from Tibet to sea level are often described by returning riders as “supercharged” — the elevated hematocrit and the now-abundant atmospheric oxygen combine to produce a measurable performance boost. The published athletic-training literature on altitude training is built around exactly this effect: athletes who train at altitude and compete at sea level access a temporary window of enhanced oxygen-carrying capacity. For a Tibet motorcycle rider this same window produces an unexpected sense of physical capability in the first days after the trip. Pierre, a Marseille-based physiotherapist on a 2024 Tibet expedition, ran a personal-best 10-kilometre time three days after returning to Bangkok, on the trip’s adapted hematocrit. The effect is real.

The window closes over the next seven to fourteen days as the body’s regulatory mechanisms reduce erythropoiesis and the older elevated-altitude red blood cells reach the end of their natural 120-day lifespan. By day ten post-descent, hematocrit is approaching pre-trip baseline. By day fourteen, the adaptation is largely undone. The cardiovascular system relaxes back to sea-level demands. Sleep architecture normalises. Appetite returns to baseline. The “Tibet stare” resolves entirely.

A few descent-phase phenomena are worth knowing. Some riders experience “oxygen abundance fatigue” in the first days post-descent — paradoxical sleepiness from the body’s adjustment to easier oxygen availability. This typically resolves in 48 to 72 hours. A few riders experience mild edema in the legs and feet as the contracted plasma volume re-expands. This also resolves within a week. Riders who had AMS symptoms during week one often report that the first 48 hours back at sea level reproduce a milder version of the same symptoms, which clinicians call “reentry sickness.” The mechanism is not fully understood but the resolution is reliable.

What the science says about hyperbaric chambers in Lhasa

Several Lhasa hospitals operate hyperbaric chambers specifically for severe acute mountain sickness, high-altitude pulmonary edema, and high-altitude cerebral edema. The chambers simulate descent by pressurising the patient to roughly 2,000 metres equivalent atmospheric pressure for a few hours, allowing emergency treatment without the logistics of an actual descent. For severe HAPE or HACE, the chambers are life-saving. For routine AMS, they are not needed and not appropriate — most riders with mild AMS recover with rest, hydration, and Diamox.

The decision to seek hyperbaric treatment is made by the local medical team in Lhasa in consultation with the tour operator. Big Bike Tours and other established Tibet operators have direct relationships with the People’s Hospital of Tibet Autonomous Region and the Lhasa First People’s Hospital, both of which have functioning hyperbaric chambers. The relationships matter because the chambers are not always available without prior coordination, and the language barrier between foreign patients and Lhasa medical staff is significant.

Maria, a Madrid-based commercial pilot on a 2024 Tibet tour who developed early HAPE symptoms on day three at Yamdrok Lake, was evacuated to Lhasa, treated for four hours in the hyperbaric chamber, and was riding again on day six after additional acclimatization. Without the chamber, the standard treatment would have been immediate descent to Chengdu or Kathmandu — a multi-day disruption that would have ended her trip. With the chamber, she completed the full 20-day Tibet and Shangri-La itinerary. The infrastructure exists for a reason.

Practical implications for the rider

The week-by-week physiology has direct operational implications. Hydration discipline must be maintained throughout, not just in week one. Four to five litres of water per day across all four weeks. Alcohol intake should be zero or near-zero for the entire trip — alcohol interacts badly with the periodic-breathing pattern and worsens sleep quality at altitude. Sleeping at lower elevations when the itinerary allows (descending to 3,500 metres for the night even when the day’s riding goes to 5,000) significantly improves recovery.

Riding pace should remain conservative throughout. Week-one cautious pace is obvious. Week-four cautious pace is less obvious but equally important — the cumulative cognitive fatigue and the late-onset cardiovascular strain mean that reflexes are slower in week four than in week two, even if the rider feels comfortable. Group leaders should explicitly set a sustainable pace for the longer trips, not just the opening days.

Knowing when to bail is the most important and least practised altitude skill. Persistent severe headache that does not respond to ibuprofen, increasing cough with frothy or pink sputum, confusion or unsteady gait, or a resting heart rate that climbs past 100 bpm at rest are all signals to descend immediately, not signals to push through. The Tibet trip will still be there next year. The rider needs to be alive to come back to it. Magnus, a Copenhagen-based architect on a 2025 Tibet tour, made the right call to descend at day five of his trip when his SpO2 stayed below 80 percent at Shigatse despite acclimatization. He came back six months later, completed the full trip, and counted the first attempt as a learning experience. The honest decision in real time is what made the second attempt possible.

Plan the trip around the body, not against it

The Tibet motorcycle tour is one of the more physiologically demanding civilian travel experiences available, and the four-week itineraries are a different category of challenge from the standard 10-day Asian motorcycle holidays. The body adapts, with costs and benefits that change week by week. Knowing the curve before you ride it produces better decisions during the trip and better physical preservation after it. Big Bike Tours runs the 20-day Tibet and Shangri-La motorcycle tour with built-in acclimatization stops, daily medical monitoring, oxygen supply on the support vehicle, and established relationships with Lhasa hospitals for the rare medical event. Get in touch via our contact page well ahead of the trip to discuss medical clearance and to confirm that the four-week altitude exposure fits your specific health profile.